Drug Shortage Report for NRA-TADALAFIL TABLETS
| Report ID | 38038 |
| Drug Identification Number | 02452480 |
| Brand name | PRIVA-TADALAFIL |
| Common or Proper name | TADALAFIL 5 MG |
| Company Name | NORA PHARMA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | TADALAFIL |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 7X4 |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2018-02-01 |
| Actual start date | 2018-02-01 |
| Estimated end date | |
| Actual end date | 2018-04-02 |
| Shortage status | Resolved |
| Updated date | 2025-06-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1565 LIONEL-BOULET BLVD. VARENNES, QUEBEC CANADA J3X 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-04-03 | English | Compare |
| v3 | 2018-02-02 | English | Compare |
| v2 | 2018-02-01 | French | Compare |
| v1 | 2018-02-01 | English | Compare |
Showing 1 to 4 of 4